Plain-English translation of NCT05805436 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
After robotic urologic surgery—such as prostate or kidney removal—many patients experience delayed return of bowel function and digestive problems like nausea, bloating, and constipation for days or weeks. This trial is testing whether taking polyethylene glycol (a common, over-the-counter bowel-cleaning medication also known as MiraLAX) for three days before surgery can help speed up bowel recovery and reduce these uncomfortable digestive symptoms. All participants will also receive the standard bowel-care medications after surgery, but half will receive the medication beforehand and half will not.
After minimally-invasive robotic urologic surgery, patients commonly struggle with delayed bowel recovery and ongoing digestive discomfort. Doctors want to see if starting bowel preparation before surgery—rather than waiting until after—might help patients feel better and recover faster.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly assigned to either take the bowel-cleaning medication for three days before your scheduled surgery or to skip that step. Both groups will receive the standard bowel-care medications after surgery and during your hospital stay. You will be asked to keep a diary and complete questionnaires to track when your bowel function returns and what digestive symptoms you experience during your recovery at home.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
United States